114 related articles for article (PubMed ID: 8961963)
1. Modifying risks of secondary leukemias: is drug scheduling important?
Karp JE; Smith MA
J Natl Cancer Inst; 1996 Dec; 88(24):1787-9. PubMed ID: 8961963
[No Abstract] [Full Text] [Related]
2. DNA repair and the risk of secondary leukemias.
Gerson SL
J Clin Oncol; 1996 Feb; 14(2):681-2. PubMed ID: 8636789
[No Abstract] [Full Text] [Related]
3. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
4. [Leukemias induced by anticancer chemotherapies].
Harousseau JL
Bull Cancer; 1999 Nov; 86(11):929-38. PubMed ID: 10586109
[TBL] [Abstract][Full Text] [Related]
5. Insights into leukemogenesis from therapy-related leukemia.
Pedersen-Bjergaard J
N Engl J Med; 2005 Apr; 352(15):1591-4. PubMed ID: 15829541
[No Abstract] [Full Text] [Related]
6. A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias.
Ellis M; Ravid M; Lishner M
Leuk Lymphoma; 1993 Sep; 11(1-2):9-13. PubMed ID: 8220158
[TBL] [Abstract][Full Text] [Related]
7. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide.
Chen CL; Fuscoe JC; Liu Q; Pui CH; Mahmoud HH; Relling MV
J Natl Cancer Inst; 1996 Dec; 88(24):1840-7. PubMed ID: 8961974
[TBL] [Abstract][Full Text] [Related]
8. Leukemia after chemotherapy for cancer.
Chasen MR; Falkson G
Cancer Biother; 1993; 8(2):115-22. PubMed ID: 7804352
[No Abstract] [Full Text] [Related]
9. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and leukemia: the forest for the trees?
Hudis C
Ann Surg Oncol; 2002 Oct; 9(8):717-8. PubMed ID: 12374652
[No Abstract] [Full Text] [Related]
11. Function of topoisomerase II and the consequences of inhibition.
Davies SM
Med Pediatr Oncol Suppl; 1996; 1():12-9. PubMed ID: 8643041
[No Abstract] [Full Text] [Related]
12. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
13. Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms.
Ozga M; Blachly J; Eisfeld AK; Grieselhuber N; Larkin K; Walker A; Bhatnagar B; Behbehani G; Long M; Haque T; Vasu S; Zhao W; Jones D; Byrd JC; Mims AS; Saygin C
Am J Hematol; 2021 Jul; 96(7):E223-E225. PubMed ID: 33761147
[No Abstract] [Full Text] [Related]
14. Tracking chemotherapy's effects on secondary cancers.
Brower V
J Natl Cancer Inst; 2013 Oct; 105(19):1421-2. PubMed ID: 24052617
[No Abstract] [Full Text] [Related]
15. [Therapy-related acute myeloid leukemia: role of DNA repair].
Guièze R; Ravinet A; Hermet E; Maliki Y; de Botton S; Bay JO
Bull Cancer; 2011 Mar; 98(3):247-55. PubMed ID: 21427028
[TBL] [Abstract][Full Text] [Related]
16. The secondary leukemias: challenges and research directions.
Smith MA; McCaffrey RP; Karp JE
J Natl Cancer Inst; 1996 Apr; 88(7):407-18. PubMed ID: 8618232
[TBL] [Abstract][Full Text] [Related]
17. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.
Smith MA; Rubinstein L; Anderson JR; Arthur D; Catalano PJ; Freidlin B; Heyn R; Khayat A; Krailo M; Land VJ; Miser J; Shuster J; Vena D
J Clin Oncol; 1999 Feb; 17(2):569-77. PubMed ID: 10080601
[TBL] [Abstract][Full Text] [Related]
18. Thiopurines, DNA damage, DNA repair and therapy-related cancer.
Karran P
Br Med Bull; 2006; 79-80():153-70. PubMed ID: 17277075
[TBL] [Abstract][Full Text] [Related]
19. Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer.
Bokemeyer C; Schmoll HJ; Kuczyk MA; Beyer J; Siegert W
J Natl Cancer Inst; 1995 Jan; 87(1):58-60. PubMed ID: 7666466
[No Abstract] [Full Text] [Related]
20. Importance of chemotherapy scheduling: pieces of the puzzle.
Hryniuk W
Cancer Invest; 1999; 17(7):545-6. PubMed ID: 10518199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
